These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 535145)

  • 1. Evaluation of copper oxidase (ceruloplasmin) and related tests in Hodgkin's disease.
    Wolf PL; Ray G; Kaplan H
    Clin Biochem; 1979 Dec; 12(6):202-4. PubMed ID: 535145
    [No Abstract]   [Full Text] [Related]  

  • 2. Value of laboratory indicators in Hodgkin's disease: preliminary results.
    Ray GR; Wolf PH; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():315-23. PubMed ID: 4744591
    [No Abstract]   [Full Text] [Related]  

  • 3. Ceruloplasmin in Hodgkin's disease.
    Koprivová H; Dienstbier Z; Sámal M; Foltýnová V
    Neoplasma; 1982; 29(3):333-40. PubMed ID: 7133228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum ceruloplasmin levels in Hodgkin's disease and malignant lymphomas in correlation with serum copper levels.
    Sirsat AV; Raste AS; Talavdekar RV; Advani SH
    Indian J Cancer; 1979 Jun; 16(2):32-4. PubMed ID: 546729
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged observations on variations in the serum copper in Hodgkin's disease.
    Warren RL; Jelliffe AM; Watson JV; Hobbs CB
    Clin Radiol; 1969 Jul; 20(3):247-56. PubMed ID: 5808043
    [No Abstract]   [Full Text] [Related]  

  • 6. [BLOOD COPPER AND CERULOPLASMIN IN HODGKIN'S DISEASE].
    THORLING EB; JENSEN KB; ANDERSEN CJ; JENSEN K
    Folia Clin Int (Barc); 1965 Jan; 15():12-26. PubMed ID: 14311723
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of some humoral and cytological indices in active stages of Hodgkin's disease].
    Barbui T; Dini E; Chisesi T; Corà R; Franchi F; Cazzavillan M; Battista R
    Haematologica; 1972; 57(9):488-92. PubMed ID: 4125445
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
    Margerison AC; Mann JR
    Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [VARIATIONS IN SERUM COPPER OXIDASE (CERULOPLASMIN) IN THE COURSE OF MALIGNANT LYMPHOGRANULOMATOSIS].
    ZAMFIRESCU-GHEORGHIU M; PETRESCU M; GROZEA P; GOCIU M; SIGHETEA E; VLADESCU C; CUCU F
    Stud Cercet Med Interna; 1964; 5(3):263-7. PubMed ID: 14203689
    [No Abstract]   [Full Text] [Related]  

  • 10. Formal discussion of F. Teillet et al's paper, "a reappraisal of clinical and biological signs in staging of Hodgkin's disease.
    Kaplan HS
    Cancer Res; 1971 Nov; 31(11):1730. PubMed ID: 5121675
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood copper and ceruloplasmin levels in hemolymphopathies. I. Malignant lymphoma].
    Tura S; Bernardi L; Baccarani M; Sanguinetti F; Branzi A
    G Clin Med; 1968 Nov; 49(11):1090-104. PubMed ID: 5757473
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnostic value of determination of ceruloplasmin activity and haptoglobin level in patients with lymphogranulomatosis].
    Vasygova NF; Lorie IuI
    Vestn Akad Med Nauk SSSR; 1974; (12):20-4. PubMed ID: 4446705
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum ferritin and other biological parameters as indicators of tumor activity in Hodgkin's disease].
    Hermosa V; Mazo E; Baró J; Castillo E; Cordovilla JJ; Carril J; Zubizarreta A
    Sangre (Barc); 1985; 30(2):154-8. PubMed ID: 2409612
    [No Abstract]   [Full Text] [Related]  

  • 14. [Correlation between serum values of copper, ceruloplasmin, SMAO, SDAO, in health- subjects, in pregnant women and in some pathological conditions (author's transl)].
    Bombardieri G; Rossi L; Bevilacqua E; Fabiani S; Tettamanti P
    Quad Sclavo Diagn; 1976 Jun; 12(2):131-47. PubMed ID: 828961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum ceruloplasmin levels in patients of leukaemias, Hodgkin's and non-Hodgkin's lymphomas.
    Aggarwal AK; Sanwalka AB; Vadehra PL; Prabhakar BR
    Indian J Pathol Microbiol; 1984 Oct; 27(4):347-52. PubMed ID: 6534868
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevated serum Cu in Hodgkin's disease and inhibitory effects of ceruloplasmin on lymphocyte response in vitro.
    Larsen B; Heron I; Thorling EB
    Eur J Cancer (1965); 1980 Mar; 16(3):415-21. PubMed ID: 6445273
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum levels of ceruloplasmin, properdin factor B and copper in lymphoma patients.
    Casamassima A; Addabbo L; Caporusso L; Lorusso V
    Int J Biol Markers; 1991; 6(3):183-7. PubMed ID: 1791312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific oxidase activity of cord serum ceruloplasmin in the newborn.
    Louro MO; Cocho JA; Tutor JC
    Clin Chem Lab Med; 2000 Dec; 38(12):1289-92. PubMed ID: 11205695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of an enzymatic assay for the determination of serum ceruloplasmin.
    Macintyre G; Gutfreund KS; Martin WR; Camicioli R; Cox DW
    J Lab Clin Med; 2004 Dec; 144(6):294-301. PubMed ID: 15614251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invited discussion: Value of fluctuations in the serum copper level in the control of patients with Hodgkin's disease.
    Jelliffe AM
    Natl Cancer Inst Monogr; 1973 May; 36():325-6. PubMed ID: 4744592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.